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Accurate prediction of metabolism is a significant outstanding challenge in toxicology.
The best predictions are based on experimental data from in vitro systems using primary
hepatocytes. The predictivity of the primary hepatocyte-based culture systems, however,
is still limited due to well-known phenotypic instability and rapid decline of metabolic
competence within a few hours. Dynamic flow bioreactors for three-dimensional cell
cultures are thought to be better at recapitulating tissue microenvironments and show
potential to improve in vivo extrapolations of chemical or drug toxicity based on in vitro test
results. These more physiologically relevant culture systems hold potential for extending
metabolic competence of primary hepatocyte cultures as well. In this investigation, we
used computational fluid dynamics to determine the optimal design of a flow-based
hepatocyte culture system for evaluating chemical metabolism in vitro. The main design
goals were (1) minimization of shear stress experienced by the cells to maximize viability,
(2) rapid establishment of a uniform distribution of test compound in the chamber, and
(3) delivery of sufficient oxygen to cells to support aerobic respiration. Two commercially
available flow devices – RealBio® andQuasiVivo® (QV) – and a custom developed fluidized
bed bioreactor were simulated, and turbulence, flow characteristics, test compound
distribution, oxygen distribution, and cellular oxygen consumption were analyzed. Exper-
imental results from the bioreactors were used to validate the simulation results. Our
results indicate that maintaining adequate oxygen supply is the most important factor
to the long-term viability of liver bioreactor cultures. Cell density and system flow patterns
were the major determinants of local oxygen concentrations. The experimental results
closely corresponded to the in silico predictions. Of the three bioreactors examined in this
study, we were able to optimize the experimental conditions for long-term hepatocyte cell
culture using the QV bioreactor. This system facilitated the use of low system volumes
coupled with higher flow rates. This design supports cellular respiration by increasing
oxygen concentrations in the vicinity of the cells and facilitates long-term kinetic studies
of low clearance test compounds. These two goals were achieved while simultaneously
keeping the shear stress experienced by the cells within acceptable limits.
Keywords: computational fluid dynamics, fluid dynamic modeling, hepatocyte culture, metabolism, QuasiVivo,
RealBio
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INTRODUCTION
There has been a coordinated, international call to increase the
use of in vitro and in silico methods for hazard identification and
risk assessment (Dix et al., 2007; Williams et al., 2009; Adeleye
et al., 2015; De Boer et al., 2015). In response, scientists have
developed advanced three-dimensional (3D) cell cultures with
more physiologically relevant microstructures and environments
that better match those in the intact organism (Marga et al., 2012;
Kostadinova et al., 2013; Shulman and Nahmias, 2013; Ballard
et al., 2015). Compared with traditional two-dimensional (2D)
cultures, 3D cultures hold the potential to generate biological
responses from chemical exposures that are more predictive of
human in vivo responses (Zare-Mehrjardi et al., 2011; Pineda et al.,
2013).
The liver plays an important role in the systemic clearance
of xenobiotics. Currently, freshly isolated primary hepatocytes
are regarded as the most relevant experimental system to study
hepatic metabolism, as well as metabolism-mediated effects of
chemicals and pharmaceuticals (Lecluyse and Alexandre, 2010).
Freshly isolated primary hepatocytes express most of the proteins
found in the human liver, including those involved inmetabolism,
membrane transport, and receptor-mediated processes (Li et al.,
1995; Vildhede et al., 2015; Yang et al., 2015). However, one
of the major drawbacks with primary hepatocytes is the rapid
change in phenotype observed in culture. Several techniques have
recently been developed to stabilize hepatic phenotype over longer
periods, which may enhance the predictive power of primary cell
culture for in vivo responses (Vinci et al., 2010; Ballard et al.,
2015). These advanced cell culture models have shown their
ability to better mimic physiological microenvironments in the
human liver in healthy and diseased states (Chan et al., 2013;
Ballard et al., 2015). Recently, a dynamic culture device with a
3D scaffold for cell attachment [RealBio® (RB)] was tested for
long-term primary hepatocyte culture (Choi et al., 2014). In this
method, cultured primary hepatocyte suspensions are seeded into
a scaffold where they form 3D structures. The cultures remained
viable for over 7weeks andmaintained some of their liver-specific
functionality, e.g., sustained albumin production (Choi et al.,
2014). Other similar advances have also been observed with sev-
eral other culture methods (Dash et al., 2013; Ukairo et al., 2013;
Ballard et al., 2015).
There is a growing appreciation that the use of these advanced
culture systems can be beneficial for a variety of endpoints within
many fields of research (Breslin and O’Driscoll, 2016; Clevers,
2016; Leek et al., 2016). In toxicology, bioreactors have the poten-
tial to improve chemical and drug safety assessment as they are
expected to better recapitulate biological responses to chemical
exposures. The combination of exposure control and ease of
sampling with more organotypic cell cultures also make biore-
actors attractive for kinetics and metabolism investigations. The
potential ability to reproduce exposure profiles of parent chemical
and metabolites combinations within culture systems can also
improve concentration-effect responses and in vitro to in vivo
extrapolations.
Many of the bioreactor systems are flow-based culture systems,
and computational fluid dynamics (CFD) modeling is well suited
to optimize bioreactor design as it provides a tool to describe
fluid dynamics in the engineered culture devices (Kang et al.,
2013; Hsu et al., 2014). CFD modeling allows parameter values
to be varied and the effects on the system to be characterized
rapidly. This includes effects that are easier to describe math-
ematically than to measure experimentally. For instance, CFD
modeling can generate detailed descriptions of fluid flow and
nutrient transport within bioreactor systems. It can also be used
to describe spatiotemporal distributions of a test compound or
oxygenwithin the system. CFD and other computational methods
have previously been applied to enhance our understanding of
system parameters fundamental for cell responses within complex
3D culture environments (Kang et al., 2013; Hsu et al., 2014).
In this study, CFDmodeling was used to assist the development
of a flow-based hepatocyte culture system for long-term hepa-
tocyte culture suitable for extended investigations of metabolic
clearance or metabolite profile identification of low clearance
compounds. Previous data indicate that the scaffold-based RB sys-
tem supports long-term hepatocyte viability but not maintained
metabolic capabilities. We hypothesize that increased cell–cell
interactions fostered in other types of 3D culture conditions in
combination with dynamic flow culture could improve the phe-
notypic stability. Two other bioreactors, QuasiVivo® (QV) and
fluidized bed (FB), were tested for this reason. They do not require
a specialized scaffold but are compatible with some existing 3D
methods for long-term hepatocyte culture, including alginate-
encapsulated hepatocytes. CFD models were developed for the
RB, QV, and FB bioreactors with the aim to identify a bioreactor
suitable for alginate bead culture.
MATERIALS AND METHODS
Materials
William’s E medium was purchased from Life Technologies
(Grand Island, NY, USA). Trypan blue (TB) and
7-ethoxycoumarin were purchased from Sigma-Aldrich (St.
Louis, MO, USA). RB bioreactors were purchased from RealBio®
Technology, Inc. (Kalamazoo, MI, USA). Quasi-Vivo® bioreactors
were provided by Kirkstall Ltd. (Rotherham, UK). The FB
bioreactor was manufactured by Professor Jeffrey M. Macdonald
and Vaibhav Hans, University of North Carolina (Chapel Hill,
NC, USA).
Bioreactor Design
Three bioreactor systems (RB, FB, and QV) were selected for
inclusion in the current study. Diagrams of these systems are
shown in Figure 1.
The RB bioreactor (Figures 1A,B) is a scaffold-based system
where hepatocyte suspensions are seeded and cultured on a 3D
woven polycarbonate scaffold (Pfund et al., 2013). The 1-mm
thick scaffold is maintained between two media compartments
with dynamic flow. Both media compartments are in equilib-
rium with gas compartments through gas-permeable membranes
(Figures 1A,B). All flows were modeled as concurrent, and all
media inlets and outlets were of 1-mm internal diameter (ID). The
total volume of the RB bioreactor is 7.0mL.
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FIGURE 1 | 2D (A,C,E) and 3D (B,D,F) geometry models of the bioreactors used in the simulations. 2D models are from COMSOL; 3D models are from
Solidworks. The three bioreactor types are RealBio (A,B), fluidized bed (C,D), and QuasiVivo (E,F).
The FB bioreactor (Figures 1C,D) was custom developed
specifically for use with alginate-encapsulated primary
hepatocytes. This bioreactor was machined from polysulfone
and consists of three main parts: top and bottom pieces creating
two chambers for media and a spacer piece wherein the cell
compartment is located (Figures 1C,D). The FB bioreactor has a
total volume of 4.8mL. The cell compartment is separated from
the media compartments with two polypropylene filters with
100-μm pore size. The media inlet was 1.5-mm ID, and the outlet
was 3-mm ID.
The QV bioreactor (Figures 1E,F) has a single compartment
with a single media inlet (1-mm ID) and outlet (2-mm ID)
(Gordon et al., 2014). The volume of the chamber is 4.0mL, and
it can accommodate 2D or 3D cell cultures. 2D cultures are
supported on a slide that rests on six small projections from the
floor of the chamber, while alginate-based 3D cultures can be
added to the chamber without the slide. The base of the bioreactor
is made of Altuglas SG7 acrylic, while the lids are a styrene-
based thermoplastic elastomer (TPE). The QV chamber has a
polycylindrical shape with a slanted “roof ” and offset outletmeant
to promote mixing and reduce shear stress along the chamber
bottom where the cells are located.
Simulation Software
Bioreactor geometries were described using finite element model-
ing (FEM) algorithms as implemented in COMSOL Multiphysics
4.3 (The COMSOL Group, Stockholm, Sweden) and Solidworks
2013 (Dassault Systems, Waltham, MA, USA) (Figure 1). Most
simulations were performed using COMSOL’s stationary solver
that finds time-invariant solutions. Simulations of test compound
distribution were performed using COMSOL’s time-dependent
solver up to t= 60min. The remaining simulations were per-
formed using Solidworks.
Fluid Dynamics Modeling
Flow velocity, turbulence, and shear stress profiles in each biore-
actor were investigated using 2D and 3D CFD modeling. Fluid
motion within the bioreactors was described by a Navier–Stokes
equation assuming incompressible, isothermal Newtonian flu-
ids. Equation 1 describes the momentum balance, while Eq. 2
describes continuity within incompressible fluids.
ρ@u
@t   μr
2u+ ρ(u  r)u+rP = F (1)
r  u = 0 (2)
where ρ is density (kilograms per cubicmeter),μ is viscosity (kilo-
grams per meter per second), P is pressure (kilograms per meter
per square second), F is volume force (kilograms per squaremeter
per square second), u is the 3D velocity field (meter per second),
and 5 is del (aka nabla) operator, r = ~ex @@x + ~ey @@y + ~ez @@z
for Cartesian coordinates (Buchwald, 2011). Model parameters
used were viscosity= 10 3 kg/m/s, fluid density= 1000 kg/m3,
temperature= 37°C, and no-slip boundary conditions. The volu-
metric flow rate was 0.5mL/min (QV) or 1mL/min (RB and FB).
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FIGURE 2 | Three variations on the fluidized bed (FB) bioreactor with different spatial dimensions using Solidworks. (A–C) Flow particle study results and
(D–F) flow trajectory study results shown from the top. Option 1: 27.3mm maximum width (A,D); Option 2: 22.2mm maximum width (B,E); and Option 3: 16.7mm
maximum width (C,F).
Outlets weremodeledwith a pressure of 0 kg/m/s2 with no viscous
stress or environmental pressure.
Shear stress experienced by the cells was described with Eq. 3.
The properties of cell culture media were assumed to be identical
to those of water, the reference fluid.
τwall = μ

@u
@y

y=0
; τwall = τcells (3)
where τ is shear stress (kilograms per meter per square second),
μ is viscosity (kilograms per meter per second), u is flow velocity
parallel to the wall (meter per second), and y is the distance to the
wall (meters).
Bioreactor fluid dynamic models were developed for 2D and
3D geometries. The pore size of the RB bioreactor scaffold was
modeled as 100μm. For the FB bioreactor, a porosity factor of
0.3 was used to simulate alginate beads in the cell compartment.
Sensitivity analysis showed no significant differences in cell com-
partment flow for porosity values from 0.1 to 0.7. The filters on
either side of the FB cell compartment were modeled as a 100-μm
thick layer with evenly distributed pores of 100-μm diameter. To
investigate the impact of the choice of spatial dimensions for the
FB bioreactor, three variations of the width of the FB parabola
were modeled: 27.3, 22.2, and 16.7mm corresponding to the
original (Figure 2A), narrow (Figure 2B), and oval (Figure 2C)
design, respectively.
Simulation of Small Molecule and Oxygen
Distributions
The CFD models described in Section “Fluid Dynamics Mod-
eling” were used to simulate the spatiotemporal distribution of
oxygen and a representative small molecule in each bioreactor.
Parameters describing these simulations are listed in Table 1.
TABLE 1 | Physical constants used in the CFD models to describe the
mass transport of oxygen and a small molecule test compound in each
bioreactor.
Parameter name Value Reference
DO2 , O2 diffusion coefficient
in aqueous media
310 9 m2/s Mazzei et al. (2010) and
Buchwald (2011)
Cell-normalized O2
consumption rate in
hepatocytes
0.4 nmol/s/106 cells Balis et al. (1999)
km, Michaelis–Menten
constant
5.6mmHg Foy et al. (1994) and
Allen and Bhatia (2003)
ccr, critical O2 concentration 2.8210 3 mol/m3 De Groot et al. (1988)
C0, O2 concentration at inlet 0.214mol/m3 Mazzei et al. (2010)
KO2 , Henry’s law constant 932.4 atm/mol/L Mazzei et al. (2010)
Dtest, test compound diffusion
coefficient
110 8 m2/s Estimated
O2 solubility 0.2mol/m3 USGS (2016)
Test Compound Distribution
In our simulations, the test compound enters the bioreactor
through the inlet at a fixed concentration, as described in Section
“Experimental Studies for Small Molecule Distribution.” Mass
transport was by advection and diffusion, as described below
(Eq. 4):
@c
@t +r  ( Drc) = R  u  rc (4)
where c is the 3D chemical concentration (moles per cubic
meter), D is the chemical-specific diffusion coefficient (square
meter per second), R is the reaction rate (moles per cubic meter
per second), and u is 3D velocity field (meter per second)
(Buchwald, 2011). For the purpose of this study, metabolism
was not included and R= 0mol/m3/s for the test compound was
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used. The diffusion coefficient for a small molecule was set at
1 10 8 m2/s (Brody and Yager, 1997; Macdonald et al., 1999).
A sensitivity analysis using a range of diffusion coefficients from
1 10 6 to 1 10 10 m2/s showed minimal influence of this
parameter on the time it took to establish a uniform distribution
of the test compound in the bioreactors.
Oxygen Distribution
Mass transport of oxygen was handled similarly to that of the test
compound. Oxygen diffusion was described using Eq. 4 but using
a diffusion coefficient of 3 10 9 m2/s (Buchwald, 2011). The
concentration of oxygen in themedia at t= 0was assumed to be in
equilibrium with the concentration of oxygen in air, as described
by Henry’s law (Eq. 5).
PO2 = KO2  C0 (5)
where KO2 is the Henry’s law constant and PO2 is the partial
pressure of oxygen in air. See Table 1 for a list of parameter
values and references. The concentration was also used as the
concentration of oxygen in the media entering the bioreactor,
and the concentration of oxygen in the media at the air–liquid
interface membranes in the RB and FB bioreactors.
In the presence of cells, local oxygen concentrationswill depend
on mass transport of oxygen in the bioreactor and the rate of
oxygen consumption by the cells. The rate of oxygen consump-
tion by the cells was assumed to follow Michaelis–Menten (MM)
kinetics (Eq. 6). A step-down function was used to simulate the
reduction in the rate of oxygen consumption as the local con-
centration of oxygen approaches the critical concentration for
cell survival (2.8μM) as previously described (De Groot et al.,
1988). This approach has been shown to improve cellular oxygen
consumption predictions at low oxygen concentrations.
R = Vmax  cc+ km  δ(c > ccr) (6)
δ(c> ccr) =
8>><>>:
0 for c <  ccr
0:5+ 0:75

c
ccr

  0:25

c
ccr
3
for   ccr c ccr
1 for c > ccr
(7)
where Vmax is the maximal oxygen consumption rate (moles per
cubic meter per second), km is the MM constant (moles per cubic
meter), ccr is the critical oxygen concentration (moles per cubic
meter), and δ is the step-down function used to simulate the
decline in oxygen consumption by the hepatocytes when local
oxygen concentrations approach ccr (Eq. 7). See Table 1 for a
list of parameter values and references. A cell-normalized oxygen
consumption rate of 0.4 nmol/s/106 cells was used, along with a
km value of 5.6mmHg (Rotem et al., 1992; Balis et al., 1999).
The total number of cells in the RB, FB, and QV bioreactors
was estimated at 15, 70, and 1.5 million cells, respectively. Vmax
values were calculated by multiplying the cell-normalized oxygen
consumption rate by the number of cells in the bioreactor and then
dividing by the volume of the cell compartment. Cell numbers
were estimated based on seeding density (RB) or the volume of
alginate beads added to the bioreactor (FB and QV). Three bead
diameters were considered: 250, 500, and 1000μm. The alginate
beads were assumed to be 50% (v/v) hepatocytes, and a hepatocyte
diameter of 20μm (Kuntz andKuntz, 2008) was used to convert to
total cell number. The FEM algorithm as applied in COMSOLwas
used to describe local oxygen concentrations within the beads. All
oxygen transport simulations were run using the stationary solver.
Experimental Studies for Small Molecule Distribution
Two small molecules were used as test compounds, 7-
ethoxycoumarin (7EC) and TB. Each was tested separately.
The compound was added to the cell-free system using matched
flow and other incubation conditions used for fluid dynamic
modeling described above. The media was continuously
recirculated through the system with a peristaltic pump. William’s
E medium with 10μM 7EC or 0.04% TB was flowed through
each bioreactor in the absence of cells. The media leaving the
reactor was sampled up to 60min (RB) or 30min (FB and
QV) to determine compound distribution kinetics. Compound
sample concentrations were determined by fluorescence (7EC,
excitation at λ= 323 nm, emission at λ= 386 nm) or absorbance
(TB, λ= 580 nm). Results were normalized to the maximum
concentration that was measured in the time course.
RESULTS
Optimizing Chamber Design in the
FB Bioreactor
As the FB bioreactor was developed in-house, we were able to alter
chamber geometry as needed. Three alternatives based on a shape
with a parabolic cross-section were considered. The “original,”
“narrow,” and “oval” designs had maximum widths of 27.3, 22.2,
and 16.7mm, respectively. The models were otherwise identical
and were investigated for the impact of these design changes to
flow pattern and turbulence. An uneven flow pattern with higher
cross-flow through the cell compartment near the bioreactor out-
let was observed in the original FB chamber (Figure 2A). With
the narrow parabola design, the cross-flow pattern shifted to be
stronger nearer the inlet (Figure 2B). The uneven flow pattern
near the cell compartment was observed again near the outlet for
the oval design (Figure 2C). No turbulence was observed in any
of the FB chamber designs (Figures 2D–F).
Bioreactor Flow Velocity, Turbulence, and
Shear Stress
Computational fluid dynamics modeling simulated flow veloci-
ties, turbulence, and shear stress patterns within the RB, FB, and
QV bioreactors. Both 2D and 3D models of velocity were exam-
ined. Turbulence and shear stress were analyzed using 3Dmodels.
RB Bioreactor
Two-dimensional simulations of the RB bioreactor showed peak
flow velocities of 2.9 10 3 m/s and 6.2 10 4 m/s at the cham-
ber inlet and scaffold level, respectively (Figure 3A). 3D sim-
ulations showed peak flow velocity at the chamber inlet to be
0.0137m/s, approximately five times higher than the 2D predic-
tions. 3D simulations also showed velocities at the scaffold ranging
from 1 to 8 10 5 m/s, depending on the position (Figure 4A).
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FIGURE 3 | 2D simulation of flow velocity in the bioreactors using COMSOL: RealBio (A), fluidized bed (B), and QuasiVivo (C). The volumetric flow rate
was 1mL/min (RealBio and fluidized bed) or 0.5mL/min (QuasiVivo).
Flow was predicted to be laminar throughout the bioreactor, with
turbulence possible only near the inlet and outlet where there
are large constrictions or expansions (Figure 4D). Media cross-
flow through the scaffold was observed between the two compart-
ments, with predicted scaffold shear stress levels between 34.6 and
484μPa (Figure 4G).
FB Bioreactor
Two-dimensional simulations of the FB bioreactor showed a peak
inlet flow velocity of 8.02 10 3 m/s and cell compartment veloc-
ities ranging from 1 to 2 10 3 m/s (Figure 3B). 3D simula-
tions showed a peak inlet velocity of 5.76 10 3 m/s and cell
compartment flow velocities of 1–9 10 4 m/s (Figure 4B). The
velocity in the cell compartment near the inlet was 9.8 10 4 m/s.
No turbulence was observed in the FB bioreactor (Figure 4E).
Cell compartment shear stress ranged from 1070 to 4260μPa
(Figure 4H).
QV Bioreactor
Two-dimensional simulations of the QV bioreactor showed a
peak inlet flow velocity of 4.45 10 3 m/s and velocities near
the alginate beads at the bottom of the chamber of 2 10 7 m/s
(Figure 3C). 3D simulations showed a peak inlet velocity of
0.022m/s, almost five times higher than the 2D predictions. The
velocity near the alginate beads varied by position in the range of
3–15 10 6 m/s (Figure 4C). Some turbulence was observed in
the QV bioreactor in the downward flow paths after the inlet, as
well as at the periphery of the bottom of the chamber (Figure 4F).
QV shear stress near the alginate beads varied by position in the
range of 4–57μPa (Figure 4I). These results are in good agreement
with those previously reported for a variation of this bioreactor
from the same manufacturer (Mazzei et al., 2010).
Test Compound Mass Transport in the
Bioreactors
CFD Modeling Results
Two and three-dimensional CFD modeling was used to simulate
mass transport of a representative small molecule in the three
bioreactors. The 2D model predicted uniform compound distri-
butions at 18, 6, and 6min in the RB, FB, and QV bioreactors,
respectively. Figures 5A–C show the concentration of a small
molecule after 6min. The corresponding 3D models predict it
would take 40, 8, and 17.5min for a small molecule to dis-
tribute uniformly in the RB, FB, and QV bioreactors, respectively.
Figures 5D–F depict the concentration of a small molecule after
10min. When compared, the FB bioreactor models resulted in
similar predications using either 2D or 3D models. However, for
the RB and QV bioreactors, the predicted time to equilibration
was two to three times higher in the 3D predictions compared
to the 2D.
Experimental Results
7-ethoxycoumarin and trypan blue were added to the media at
the bioreactor inlet, and the media was sampled at the bioreactor
outlet. The concentration at the outlet was normalized to the
maximumconcentrationmeasured. The results of this experiment
show that it took 25min (RB), 8min (FB), and 10min (QV) for
the outlet concentration to reach equilibrium (Figures 6A–C).
In the QV bioreactor, the outlet concentration rose rapidly to a
maximum and then began falling again (Figure 6C). This result is
consistent with equilibration in a recirculating system where the
flow initially carries the chemical through the bioreactor in a cur-
rent along the top of the chamber, followed by slower back-mixing
inside the chamber causing a drop in the outlet concentration over
time. In this scenario, using the initial peak would underestimate
the time to system equilibration.
For the FB bioreactor, both 2D and 3D CFD predictions were
found to be in agreement with the experimental data. For the RB
bioreactor, 2D predictions resulted in a 28% underestimation of
the time to equilibration, while the corresponding 3D prediction
resulted in a 60% overestimation. A similar pattern was observed
for the QV bioreactor, and time to equilibration was underesti-
mated by 40% by the 2D predictions and overestimated by 75%
by the 3D predictions. In general, the 2D models averaged at a
1.6-fold underestimation of the time to equilibration, while the
3Dmodels resulted in an average of 1.4-fold overestimation of the
time to equilibration.
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FIGURE 4 | 3D simulation of flow velocity and shear stress in the bioreactors. (A–C) Velocity profiles of bioreactors shown in the vicinity of the cell
compartment/scaffold (COMSOL). (D–F) Flow trajectories, to identify turbulence within the chambers (Solidworks). (G–I) Shear stress profiles along the cell
compartment/scaffold surface (Solidworks). Three bioreactors are shown: RealBio (A,D,G), fluidized bed (B,E,H), and QuasiVivo (C,F,I).
Oxygen Distribution in the Bioreactors
Distribution of oxygen within the RB, FB, and QV bioreactors
was simulated using 2D and 3D models. For the RB bioreactor,
the 2D model predicted oxygen levels of 160μM, well above the
critical oxygen concentration, for the majority of the scaffold over
the first hour in culture (Figure 7A). Using the 3D CFD model,
oxygen concentrations down to 3.7μM, less than twice as high as
the critical oxygen concentration of 2.8μM, were predicted closer
to the chamber outlet and for parts of the center of the scaffold
(Figure 8A).
In the FB bioreactor, 2D simulations indicate an average oxygen
concentration of 130μM in the area of the cell compartment
after 60min, with a moderate gradient ranging from 220μM
near the inlet to 100μM at the outlet (Figure 7B). A low-oxygen
area immediately above the inlet had a local velocity and oxygen
level of 10 9 m/s and 1.9μM, respectively (Figures 3B and 7B).
However, the 3D simulation predicted a steady-state oxygen con-
centration of 4μM throughout a majority of the cell compartment
(Figure 8B). A higher oxygen of 12μMwas predicted around the
inlet.
For QV, the 2D simulation results in oxygen levels above
200μM for a majority of the cell compartment. An area with
oxygen concentrations down to 7.5μM in the area below the
inlet was observed after 60min (Figure 7C). The corresponding
3D simulation resulted in local oxygen concentrations as low as
1.4μM at the cell level of the bioreactor (Figure 8C).
Optimization of Flow Rate and Oxygen
Partial Pressure in the QV Bioreactor
Simulations of the QV bioreactor showed favorable results for
compound distribution and shear stress levels close to the alginate
beads. However, predicted oxygen levels were too low to sup-
port the alginate-encapsulated 3D hepatocyte culture. Different
media flow rates and external oxygen concentrations were there-
fore modeled to optimize the QV system for applications involv-
ing alginate-encapsulated 3D hepatocyte culture. As presented
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FIGURE 5 | Simulation of compound distribution in the bioreactor using Solidworks. Chemical species transport simulated with 2D models at 6min (A–C) or
3D models at 10min (D–F).
FIGURE 6 | Experimentally measured concentrations of 7-ethoxycoumarin (blue diamonds) or trypan blue (red squares) exiting the bioreactor,
expressed as a percentage of the maximum detected concentration. Results for RealBio (A), fluidized bed (B), and QuasiVivo (C).
in Section “Oxygen Distribution in the Bioreactors,” the local
oxygen concentration at the bottom of the QV bioreactor was
predicted to be 1.4μM at a flow rate of 0.5mL/min. This local
oxygen concentration increased to 1.7 and 33μM at flow rates
of 1.5 and 3mL/min, respectively (Figure 9). Variations in local
oxygen concentrations at the bottom of the QV bioreactor were
investigated at the atmospheric level of 21% oxygen, as well
as at 35 and 50% oxygen. When modeled using a 1.5mL/min
initial flow rate, the local oxygen concentration increased from
1.7μM to 43 and 180μM at 35 and 50%, respectively (Figure 10).
The results suggest that increased flow rate and higher exter-
nal oxygen concentration would be beneficial to increase QV
applicability for alginate-encapsulated 3D culture of primary
hepatocytes.
Oxygen Distribution within Alginate Beads
Local oxygen concentrationswithin alginate and hepatocyte beads
were investigated for 250, 500, and 1000μm diameter beads using
2D and 3D simulations. The initial media concentration was set
to 214μM, as calculated using Eq. 5.
The 2D simulations show steady-state oxygen concentrations
at the center of the beads of 175, 25, and 4μM for bead diameters
of 250, 500, and 1000μm, respectively (Figure 11, top row). All
oxygen concentrations were predicted to be above the critical
oxygen concentration of 2.8μM, although by less than a factor of
2 for the 1000μm beads. Corresponding 3D simulations resulted
in steady-state oxygen concentration at the center of the beads of
200, 150, and 6μM for bead diameters of 250, 500, and 1000μm,
respectively (Figure 11, bottom row).
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FIGURE 7 | 2D simulation of oxygen concentration in the bioreactors using COMSOL. Results for RealBio (A), fluidized bed (B), and QuasiVivo (C).
FIGURE 8 | 3D simulation of oxygen concentration in the bioreactors using COMSOL. Results for RealBio (A), fluidized bed (B), and QuasiVivo (C).
FIGURE 9 | 3D simulation of oxygen concentration in the QuasiVivo for different flow rates using COMSOL. Results for 0.5mL/min (A), 1.5mL/min (B),
and 3mL/min (C).
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FIGURE 10 | 3D simulation of oxygen concentration in the QuasiVivo for different oxygen percentages in the gas phase at a flow rate of 1.5mL/min
(COMSOL). Results for 21% O2 (A), 35% O2 (B), and 50% O2 (C).
FIGURE 11 | Simulation of oxygen concentration inside beads of alginate-encapsulated hepatocytes using COMSOL. 2D model results (top row) and 3D
model results (bottom row) for the RealBio (left column), fluidized bed (center column), and QuasiVivo (right column) bioreactors.
DISCUSSION
Over the past decade, there has been an increase in the use
of flow-based, long-term culture systems (i.e., “bioreactors”) for
many purposes, including the investigation of organ function
and cell metabolism. Several hepatic bioreactor systems have
been developed with the aim to recapitulate parts of the com-
plex in vivo microenvironment to better maintain the in vivo
hepatocyte phenotype over time in culture. Typical parts of this
microenvironment include extracellular factors, such as cell–cell
interactions, cell–matrix interactions, chemical microenviron-
ment, or physical parameters, such as shear stress (Kuntz and
Kuntz, 2008; Lecluyse et al., 2012). Examples of advanced mod-
els include scaffold-based 3D cultures, spheroid cultures, or
alginate-supported 3D culture. Several of these culture meth-
ods maintain hepatocyte morphology and viability over many
weeks and previous results indicate that the inclusion of dynamic
media flow extends the primary hepatocyte viability even further
(Dash et al., 2013; Ukairo et al., 2013; Choi et al., 2014). With the
expansion of the use of flow-based systems, CFD modeling has
been an important tool to describe internal bioreactor parameters.
CFDmodeling enables rapid assessment of bioreactor parameters
such as internal flow velocity, shear stress, and oxygen concentra-
tion that are difficult to determine experimentally. In the present
study, CFD modeling was used in three different liver bioreactors
as a long-term culture system for primary hepatocytes on 3D
scaffolds or in alginate-encapsulated 3D beads. Bioreactor and
operational parameters were optimized for use in chemical and
drug safety assessments, more specifically for studying xenobiotic
metabolism. It should be noted that all of the bioreactors inves-
tigated here were designed and optimized by their inventors for
purposes other than long-term hepatocyte culture. Our goal was
to identify design criteria for optimizing the bioreactors for assess-
ingmetabolism and to use computational modeling to explore the
advantages and disadvantages of each system when used for our
purposes.
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An initial exploration was conducted to examine the effect
of altering the spatial dimensions of the FB bioreactor to see if
improvements could be made to the existing system. Examination
of the results from the original system (Figures 2A,D) versus
the two alternative systems (Figures 2B,E,F) showed no major
improvements. Because no advantage could be observed, the
original design was carried forward for future modeling studies.
Two- and three-dimensional models describing the geometry
of the three bioreactors were built using two software platforms,
COMSOL and Solidworks (Figure 1). Velocity fields were gen-
erated using these models to better understand how fluid moves
through each system. The RB and FB bioreactors both had simple
velocity fields, with fluid moving from inlet to outlet past and
through the hepatocyte layer (Figures 4D–E). The RB bioreactor
contains a scaffold where hepatocytes are seeded directly, flanked
on both sides by two media compartments that are in commu-
nication with reservoirs of air via gas-permeable membranes to
facilitate greater media oxygenation. Each media compartment
possesses its own inlet and outlet, but they are angled so as to
encourage a small amount of cross-flow through the scaffold. The
FB bioreactor has one inlet and one outlet and is seeded with algi-
nate supported 3D cell cultures in the cell compartment situated
between the inlet and outlet. Media entering the bioreactors must
flow through the alginate beads before exiting from the opposite
side of the bioreactor. In both cases, the flow is almost entirely
unidirectional.
In this study, the QV bioreactor is used for the culture of
alginate-encapsulated 3D hepatocytes, just as the FB bioreactor.
The outlet is offset from the inlet resulting in the media flow
tangential to the cell compartment at the bottom of the cham-
ber. A substantial portion of the flow establishes a circulatory
pattern with subsequent mixing in the lower half of the chamber
(Figure 4F). Unlike the RB or FB bioreactors, the QV system had
areas with negligible flow (Figures 4D–F).
Flow regime is another factor to be considered during the opti-
mization process. Turbulent flow can affect local shear stress as
well as introduce a chaotic element into the modeling process. No
turbulence was predicted for the FB bioreactor and was minimal
for the RB and QV bioreactors at the volumetric flow rates under
consideration. As such, it was not a major consideration when
choosing between the three systems.
Shear stress experienced in the vicinity of the cells was also
modeled (Figures 4G–I). A low level of shear stress provides a
better representation of the in vivo microenvironment and may
improve hepatocyte viability and phenotype stability (Dash et al.,
2013; Choi et al., 2014). Conversely, too much shear stress will
introduce cell stress that will damage or even kill the cells. The
QV bioreactor had the lowest shear stress, followed by the RB
bioreactor, with the FB bioreactor having the highest levels.
Accurate kinetic modeling requires a high degree of certainty
regarding both the magnitude and the timing of exposure. In the
context of this study, it means that a test compound added to
the system should, in the ideal case, rapidly establish a uniform
concentration throughout the system. Through CFD modeling
(Figures 5D–F) and experiment (Figure 6), it was determined that
the FB and QV bioreactors both achieved this goal within the first
10min after dosing. The RB bioreactor took more than twice as
long to establish a uniform concentration.
In order to support cellular respiration, sufficient oxygen con-
centrations are required. CFD modeling showed that both the RB
and FB bioreactors had a minimal oxygen concentration above
the critical level throughout (Figures 8A,B). The lowest predicted
oxygen concentrations for the RB were less than twice the critical
oxygen concentration and were observed near the outlet of the
chamber and along the center of the scaffold were the media flow
was less. In our experiments with the RB system, a lower density of
cells was observed in the central region and near the outlet (Figure
S1 in SupplementaryMaterial). These areas were predicted to have
local oxygen concentrations close to the critical oxygen concentra-
tion and almost a complete lack of shear stress, which could have
impeded hepatocyte viability. In the QV bioreactor, the oxygen
concentration dropped below this level, to 1.4μM (Figure 8C).
However, by increasing the flow rate to 3mL/min (Figure 9C),
or by increasing the flow rate to 1.5mL/min and supplementing
additional oxygen gas to the system above 35% (Figures 10B,C),
the minimum oxygen concentration was brought above the crit-
ical level. Even in the presence of sufficient oxygen in the sur-
rounding media, diffusion and consumption of oxygen within the
alginate beads themselves could lead to insufficient oxygen levels
near their centers. Modeling of the beads (Figure 11) showed
that a diameter ranging from 250 to 500μm is preferable. Cell
viability of alginate supported 3D cultures of rat hepatocytes was
maintained through day 31 of culture in the lab (Figure S2 in
Supplementary Material).
The main design parameters under consideration were (1)
minimizing shear stress on the cells/alginate beads, (2) mini-
mizing the time to establish a uniform distribution of test com-
pound in the bioreactor, and (3) maintaining oxygen concen-
trations above the critical level. Taken together, the QV system
was selected because it showed the lowest shear stress of any
system under consideration, a short time scale for test compound
distribution, and sufficient oxygen availability at higher flow rates.
The low shear stresswas attributable to the placement of the cells at
the bottom of the bioreactor, away from the high velocity current
at the top of the chamber. The rapid distribution of test compound
was due to the flow pattern in the chamber, which promoted
mixing down to the bottom without high velocities that could
cause shear stress on the alginate beads.
In conclusion, CFD modeling was successfully used to ana-
lyze the applicability of three different bioreactors for extended
hepatocyte culture, with the potential for improved phenotypic
stability. The results show that CFD modeling correctly describes
and improves rapid assessments and optimizations of bioreactor
design as well as the identification of suitable systems for specific
applications. In vitro long-term chemical metabolism and kinetic
investigations in the QV bioreactor are ongoing.
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